|
(ÁÖ)¾¾¾Ø¿¡½ºÄÚ¸®¾Æ |
CRA °æ·Â»ç¿ø ä¿ë/ ¿Ü±¹°è Á¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
ä¿ë½Ã |
02.18 |
|
|
¼ºÀÎÁ¦¾à(ÁÖ) |
¼ºÀÎÁ¦¾à¢ß ºñ¼/¸¶ÄÉÆÃÀü·«¡¤±âȹ °æ·Â»ç¿ø¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ºñ¼/¾È³»/Åë¹ø¿ª |
3³â¡è |
ä¿ë½Ã |
06.14 |
|
|
Çѱ¹½ºÆ®¶óÀÌÄ¿(ÁÖ) |
Senior Sales Representative
¼¿ï °³²±¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
01.12 |
|
|
HRMakers |
À¯¸í ÀÇ·áÀåºñȸ»çÀÇ RA ´ã´çÀÚ
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
ä¿ë½Ã |
03.16 |
|
|
OOȍ |
±¹³» Áß°ß Á¦¾à»ç ¿Â¶óÀÎ ¸¶ÄÉÆà °æ·ÂÁ÷ ¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
3³â¡è |
ä¿ë½Ã |
06.01 |
|
|
(ÁÖ)¹ÙÀÌ¿ÀÄÚÁî±Û·Î¹úÄÚ¸®¾Æ |
¸¶ÄÉÆñâȹ/¿Â¶óÀθ¶ÄÉÆà °æ·Â Á¤±ÔÁ÷ ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
3³â¡è |
ä¿ë½Ã |
11.17 |
|
|
(ÁÖ)´ºÆ®¸®¹ÙÀÌ¿ÀÅØ |
(ÁÖ)´ºÆ®¸®¹ÙÀÌ¿ÀÅØ ±â¼ú¿µ¾÷ / Á¦Çü±âȹ °æ·Â Á÷¿ø ¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°Ç°º¸Á¶½ÄÇ°/ÈÀåÇ°¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
01.21 |
|
|
Novotech |
[Novotech] Business Development Manager ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ý¸í°øÇÐ/¹ÙÀÌ¿À ¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
04.04 |
|
|
ÁÖ½Äȸ»ç·ç´Ö |
(»óÀå»ç)ÇコÄɾî ÄÄÇöóÀ̾𽺠´ã´çÀÚ ¸ðÁý
¼¿ï °³²±¸ | Çз¹«°ü |
¼ö½Ãä¿ë |
3³â¡è |
»ó½Ãä¿ë |
06.09 |
|
|
ICON Clinical Research Korea |
Study Start-up Associate
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
04.22 |
|
|
ICON Clinical Research Korea |
Jr. Clinical Research Associate(Oncology)
¼¿ï °³²±¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
04.22 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) °¢ ºÎ¹® ä¿ë_°æ·Â BDS, FNS,
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Àλç/ÀÎÀç°³¹ß/ä¿ë/±³À° |
2³â¡è |
ä¿ë½Ã |
07.20 |
|
|
(ÁÖ) ¸ÞµðÆÁ |
ÀÇ·á±â±â ÀÎÇã°¡ Àü¹®°¡/°æ·Â 2³âÀÌ»ó
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
Çмú/±³À°/»ó´ã |
2³â¡è |
ä¿ë½Ã |
02.07 |
|
|
Otto Bock Korea |
¿µ¾÷Á÷ °æ·Â»ç¿ø ¸ðÁý-³ëÀÎÀå±â¿ä¾çº¸Çè°ü·Ã ¿µ¾÷ À¯°æÇèÀÚ(
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) ÀçÇÐ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
12.01 |
|
|
Otto Bock Korea |
Sales Rep.(»ç¿ø±Þ) -ÀÇ·á±â±â¿µ¾÷ À¯°æÇèÀÚ
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) ÀçÇÐ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
12.01 |
|